By FirstWord Pharma | Original Article BOSTON, May 4, 2026 - The Institute for Clinical and Economic Review (ICER) posted a Protocol today outlining how it will conduct its second annual analysis titled the “Launch Price and Access Report,” which will examine launch prices and patient access for new FDA-approved treatments. This protocol was developed with input from a multi-stakeholder working group* consisting of patient and consumer advocates, clinicians, policy experts, p

Julie Kendle, Pharm.D., Senior Director of Clinical Pharmacy at IPD Analytics, explains how managed care organizations can support patients at risk of HIV.

Julie Kendle, Senior Director of Clinical Pharmacy at IPD Analytics, explains where managed healthcare organizations should look if they want to improve PrEP access and align with public health goals.

Julie Kendle, Senior Director of Clinical Pharmacy at IPD Analytics, provides an overview of the HIV preventative medicine landscape.